{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:30:41Z","timestamp":1744209041522},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"U.K. National Institute of Health Research Clinician Scientist Award"},{"name":"NHS"},{"name":"U.K. National Institute for Health Research or the U.K. Department of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1111\/bjd.14161","type":"journal-article","created":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T19:31:49Z","timestamp":1450726309000},"page":"1125-1129","source":"Crossref","is-referenced-by-count":3,"title":["Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal"],"prefix":"10.1093","volume":"173","author":[{"given":"T.","family":"Marrs","sequence":"first","affiliation":[{"name":"Department of Paediatric Allergy; MRC-Asthma U.K. Centre; King's College London; London U.K"},{"name":"Children's Allergies; Guy's and St Thomas\u2019 Hospital NHS Foundation Trust; London U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Flohr","sequence":"additional","affiliation":[{"name":"Department of Paediatric Allergy; MRC-Asthma U.K. Centre; King's College London; London U.K"},{"name":"St John's Institute of Dermatology; Guy's and St Thomas\u2019 Hospital NHS Foundation Trust; London U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Perkin","sequence":"additional","affiliation":[{"name":"Population Health Research Unit; St George's University of London; London U.K"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"10.1111\/bjd.14161-BIB0001|bjd14161-cit-0001","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ACI.0b013e3283609671","article-title":"Randomized controlled trials investigating the role of allergen exposure in food allergy: where are we now?","volume":"13","author":"Metcalfe","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0002|bjd14161-cit-0002","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2012.02.036","article-title":"Update on risk factors for food allergy","volume":"129","author":"Lack","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0003|bjd14161-cit-0003","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","article-title":"Clinical efficacy and immune regulation with peanut oral immunotherapy","volume":"124","author":"Jones","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0004|bjd14161-cit-0004","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2222.2011.03699.x","article-title":"Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome","volume":"41","author":"Anagnostou","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/bjd.14161-BIB0005|bjd14161-cit-0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","article-title":"Oral peanut immunotherapy in children with peanut anaphylaxis","volume":"126","author":"Blumchen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0006|bjd14161-cit-0006","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0007|bjd14161-cit-0007","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0008|bjd14161-cit-0008","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0009|bjd14161-cit-0009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.14161-BIB0010|bjd14161-cit-0010","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/bjd.14161-BIB0011|bjd14161-cit-0011","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1111\/bjd.14161-BIB0012|bjd14161-cit-0012","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaci.2007.12.003","article-title":"Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center","volume":"121","author":"Summers","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0013|bjd14161-cit-0013","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/bjd.14161-BIB0014|bjd14161-cit-0014","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2222.2005.02266.x","article-title":"Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice","volume":"35","author":"Ewan","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/bjd.14161-BIB0015|bjd14161-cit-0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0016|bjd14161-cit-0016","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","article-title":"A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients","volume":"132","author":"Schneider","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0017|bjd14161-cit-0017","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.14161-BIB0018|bjd14161-cit-0018","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/pai.12013","article-title":"Why do few food-allergic adolescents treat anaphylaxis with adrenaline? Reviewing a pressing issue","volume":"24","author":"Marrs","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1111\/bjd.14161-BIB0019|bjd14161-cit-0019","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2014.12.009","article-title":"Is the use of epinephrine a good marker of severity of allergic reactions during oral food challenges?","volume":"3","author":"Santos","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1111\/bjd.14161-BIB0020|bjd14161-cit-0020","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(13)62671-9","article-title":"STOPping peanut allergy: the saga of food oral immunotherapy","volume":"383","author":"Greenhawt","year":"2014","journal-title":"Lancet"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14161","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14161\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:17:24Z","timestamp":1676384244000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/173\/5\/1125\/6616843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14161","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}